Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXHL2300312	布地奈德硫酸沙丁胺醇吸入气雾剂	budesonide;salbutamol sulfate	Inhalation	Chemical Drugs(5.1)	Import Drug Application	2023-12-12	Astrazeneca Pharmaceuticals Lp;AstraZeneca Global R&D (China) Co Ltd	view
JXHL2400036	布地奈德硫酸沙丁胺醇吸入气雾剂	budesonide;salbutamol sulfate	Inhalation	Chemical Drugs(2.4)	Import Drug Application	2024-02-20	Astrazeneca Pharmaceuticals Lp;AstraZeneca Global R&D (China) Co Ltd	view
JXHL2400148	布地奈德硫酸沙丁胺醇吸入气雾剂	budesonide;salbutamol sulfate	Inhalation	Chemical Drugs(2.2)	Import Drug Application	2024-06-25	Astrazeneca Pharmaceuticals Lp;AstraZeneca Global R&D (China) Co Ltd	view
JXHL2400147	布地奈德硫酸沙丁胺醇吸入气雾剂	budesonide;salbutamol sulfate	Inhalation	Chemical Drugs(5.1)	Import Drug Application	2024-06-25	Astrazeneca Pharmaceuticals Lp;AstraZeneca Global R&D (China) Co Ltd	view